Sign In
Buy ADC
$72.03
-0.650 (-0.89%)
At Close: Jun 03, 2026
Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company
04:00pm, Tuesday, 18'th Mar 2025
New name reflects focus on accelerating portfolio of advanced ADC therapies with speed, agility and precision Upon closing of strategic transactions, cash expected to fund operations into 2028 enablin
These 5 Dividend Stocks Will Pay You Like a Boss Every Month
03:28pm, Tuesday, 18'th Mar 2025
Dividend stocks offer a reliable way to generate monthly income without the hassles of finding a side gig, buying and managing a rental property, or any other things you learn about while doom-scrolli
Dividends Come Back Into Vogue: My Favorite Places For Income Extraction
09:15am, Tuesday, 18'th Mar 2025
Currently, we have many signs pinpointing to a value factor outperforming growth. It seems that the dividend-oriented stocks might become the new glamour. In this article, I elaborate on the key reaso
Sutro Biopharma Announces Strategic Portfolio Review Resulting in the Prioritization of its Next-Generation ADC Pipeline
04:05pm, Thursday, 13'th Mar 2025
– Sutro will rapidly advance next-generation exatecan and dual-payload ADC programs; luveltamab tazevibulin development to be deprioritized as Sutro continues to seek a partner –
Agree Realty Declares Monthly Common and Preferred Dividends
04:05pm, Tuesday, 11'th Mar 2025
ROYAL OAK, Mich. , March 11, 2025 /PRNewswire/ -- Agree Realty Corporation (NYSE: ADC) (the "Company") today announced that its Board of Directors has authorized, and the Company has declared, a mont
Realty Income Vs. Agree Realty: What Is The Best REIT To Buy In 2025?
08:25am, Monday, 10'th Mar 2025
Realty Income and Agree Realty are two of the most popular REITs. Each offers unique pros and cons to investors. But which is the best to buy today?
A $5,000 Monthly Income Portfolio For A 'SWAN' Retirement
09:15am, Friday, 07'th Mar 2025
In this article, I share a three-category portfolio approach to achieve $5,000 of durable monthly current income streams. With durable monthly distributions, I mean well-mitigated dividend cut risk an
I Am Buying These 6% Yielding Blue-Chip Dividend Stocks
08:25am, Friday, 07'th Mar 2025
Dividend stocks are today undervalued. Tech stocks are exciting, but dividend growth stocks are more rewarding. Here are a few of my favorite high-yielding blue-chip dividend stocks.
7 Stocks I'm Buying As The U.S. Economy Starts To Crack
08:05am, Saturday, 01'st Mar 2025
I emphasize the importance of nonpartisan economic and investment analysis, highlighting how political biases can distort market expectations and investment decisions. Medicaid cuts would likely have
Akeso Announces First ADC Drug Clinical Trial, Marking a New Era for "IO 2.0 + ADC" Strategy
03:58am, Thursday, 27'th Feb 2025
HONG KONG , Feb. 27, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) announced the first patient has been enrolled in the Phase I clinical trial of AK138 D1 for the treatment of advanced malignancies in Au
NEW YORK--(BUSINESS WIRE)--OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, announced the formatio
The State Of REITs: February 2025 Edition
11:59am, Friday, 21'st Feb 2025
After a brutal December (-6.85%), the REIT sector averaged negative total returns again in January (-1.29%). Large cap (+0.30%) and mid cap REITs (+0.09%) averaged small gains in January, whereas smal
Agree Realty: When The Perfect Blend Of Consistency, Reliability, And Quality Meet
10:00am, Thursday, 20'th Feb 2025
Agree Realty's strong portfolio, minimal exposure to economic downturns, and robust growth potential make it a compelling long-term hold for income-focused investors. Despite recent inflation concerns
I'm Buying Up To 9% Yield For Recurring Income
02:00pm, Wednesday, 19'th Feb 2025
The 4% rule may be outdated due to current inflation and market conditions, making income stocks all the more relevant. I highlight two quality players who offer well-covered dividends and strong busi
Building on proven targeting of the F H AB domain, Sonnet's ADC platform offers flexible payload capacity and controllable drug-antibody ratios (DAR)
